Log in to save to my catalogue

Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated i...

Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2299768558

Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation

About this item

Full title

Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation

Publisher

New York: Nature Publishing Group US

Journal title

Nature biotechnology, 2019-10, Vol.37 (10), p.1174-1185

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Therapeutic messenger RNA vaccines enable delivery of whole antigens, which can be advantageous over peptide vaccines. However, optimal efficacy requires both intracellular delivery, to allow antigen translation, and appropriate immune activation. Here, we developed a combinatorial library of ionizable lipid-like materials to identify mRNA delivery...

Alternative Titles

Full title

Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2299768558

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2299768558

Other Identifiers

ISSN

1087-0156

E-ISSN

1546-1696

DOI

10.1038/s41587-019-0247-3

How to access this item